Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model

Area of Science:

• Rheumatology
• Systemic Lupus Erythematosus (SLE) Research
• Clinical Decision-Making Models

Background:

• The Type 1 and 2 SLE Model was developed to encompass the full spectrum of signs and symptoms experienced by SLE patients.
• Previous qualitative research confirmed the model's alignment with the lived experiences of individuals with SLE.

Purpose of the Study:

• To present the Type 1 and 2 SLE Model to rheumatologists.
• To assess the model's integration into rheumatologists' clinical practice and treatment approaches for SLE patients.

Main Methods:

• A qualitative descriptive study design was employed.
• Semistructured interviews were conducted with 13 rheumatologists.
• Applied thematic analysis was used to identify key themes from the interviews.

Main Results:

• The majority of interviewed rheumatologists approved of the Type 1 and 2 SLE Model.
• Rheumatologists found the model beneficial for guiding therapy and clinical decision-making.
• The model was considered helpful for patient education regarding symptom and treatment variations, though some concerns about overdiagnosis were noted.

Conclusions:

• The Type 1 and 2 SLE Model was generally accepted by rheumatologists as a valuable tool for SLE symptom identification and treatment.
• Further research is planned to evaluate the model's impact on patient understanding, physician-patient relationships, and clinical outcomes.